Icon

FLUORODOPA F18 (nda200655)- (0.42-8.33mCi/ML)

FLUORODOPA F-18 FEINSTEIN
0.42-8.33mCi/ML
No Yes
Expired 2024-Oct-10
None None
None No
Fluorodopa F 18 Injection is a radioactive diagnostic agent indicated for use in positron emission tomography (PET) to visualize dopaminergic nerve terminals in the striatum for the evaluation of adult patients with suspected Parkinsonian syndromes (PS). Fluorodopa F 18 PET is an adjunct to other diagnostic evaluations.
0 0 0
Total Other Developers None
Drugs with Suitability No
0.42-8.33mCi/ML ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.